TG (Triglycerides) MR (Ready to Use) 1 × 100 mL (Linear®)

TG (Triglycerides) MR (Ready to Use) 1 × 100 mL (Linear®) 

Linear TG (Triglycerides) MR (Ready to Use) 1 × 100 mL is a premium clinical chemistry reagent designed for the quantitative determination of triglycerides (TG) in human serum or plasma. Manufactured by Linear Chemicals, Spain, this ready-to-use monoreagent employs the GPO-PAP (Glycerol-3-Phosphate Oxidase–Peroxidase) enzymatic colorimetric method to provide fast, accurate, and reproducible results. It is ideal for routine lipid profile testing and is compatible with both semi-automated and fully automated biochemistry analyzers, making it suitable for hospitals, diagnostic laboratories, and research institutions.

Key Features

• Ready-to-use monoreagent formulation

• Enzymatic GPO-PAP colorimetric method

• High accuracy, precision, and excellent reproducibility

• Fast reaction time with stable reagent performance

• Suitable for serum and plasma samples

• Compatible with most semi-auto and fully automated chemistry analyzers

• Ideal for routine lipid profile analysis

• Pack size: 1 × 100 mL

• CE marked and IVD (In Vitro Diagnostic) certified

Applications

• Quantitative determination of triglycerides (TG)

• Routine lipid profile testing

• Cardiovascular disease risk assessment

• Diagnosis and monitoring of hypertriglyceridemia

• Clinical chemistry analysis in hospitals and diagnostic laboratories

• Research and academic laboratory applications

Technical Specifications

• Product Name: TG (Triglycerides) MR (Ready to Use)

• Brand: Linear®

• Pack Size: 1 × 100 mL

• Method: GPO-PAP Enzymatic Colorimetric Method

• Sample Type: Serum / Plasma

• Application: Quantitative determination of Triglycerides (TG)

• Country of Origin: Spain

• For In Vitro Diagnostic (IVD) Use Only

Storage

Store the reagent at 2–8°C. Keep the bottle tightly closed and protect it from direct sunlight. Do not freeze. Proper storage helps maintain reagent stability and ensures consistent analytical performance.